Loading…
Reported covered position: Chief of Staff, HHS Office of the Asst. Sec. for Legislation (2019-2021); Policy Adviser, HHS (2017-2019); Special Asst., Office of the Secretary, HHS (2017); Staff Assistant, Rep. Tom Price (2015-2017); Intern, Rep. Doug Collins (2015)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Supporting the Local Radio Freedom Act.
Client: NATIONAL ASSN OF BROADCASTERS · Firm: TIBER CREEK GROUP
Issues related to H. Con. Res. 12/S. Con. Res. 8 - Supporting the Local Radio Freedom Act.
Supporting the Local Radio Freedom Act.
Client: NATIONAL ASSN OF BROADCASTERS · Firm: TIBER CREEK GROUP
Issues related to H. Con. Res. 12/S. Con. Res. 8 - Supporting the Local Radio Freedom Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
UNITED THERAPEUTICS CORPORATION via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to organs and xenotransplantation.
Filing targets: HOUSE OF REPRESENTATIVES
PATIENT SQUARE CAPITAL via TIBER CREEK GROUP
2026 · third_quarter · Q3
Source: Senate LDA
| AGILON HEALTH, INC. | 16 | 2023–2026 |
| Alnylam Pharmaceuticals, Inc. | 16 | 2023–2026 |
| ASTRAZENECA | 15 | 2023–2026 |
| NUSANO, INC. | 15 | 2023–2026 |
| ENERGY STORAGE ITC COALITION | 10 | 2021–2022 |
| PRIMERICA, INC. | 10 | 2024–2026 |
| COX MEDIA GROUP | 9 | 2024–2026 |
| ABBOTT LABORATORIES | 8 | 2025–2026 |
| ACADIA PHARMACEUTICALS INC | 8 | 2024–2026 |
| EVERYTOWN FOR GUN SAFETY ACTION FUND | 8 | 2025–2026 |
| GEORGIALINK PUBLIC AFFAIRS GROUP, LLC (O.B.O. DOUGHERTY COUNTY, GA) | 8 | 2025–2026 |
| SMITHS GROUP PLC | 8 | 2021–2022 |
| SOLVENTUM CORPORATION | 8 | 2025–2026 |
| INCYTE CORPORATION | 7 | 2025–2026 |
| INFUSYSTEMS HOLDINGS, INC. | 7 | 2021–2022 |
| NATIONAL ASSN OF BROADCASTERS | 7 | 2025–2026 |
| NVIDIA CORPORATION | 7 | 2022–2024 |
| RETRACTABLE TECHNOLOGIES INC | 7 | 2021–2022 |
| BICYCLE HEALTH, INC. | 6 | 2023–2024 |
| CORROHEALTH, INC. | 6 | 2025–2026 |
| MARKLOGIC | 6 | 2022–2023 |
| NATIONAL ASSOCIATION OF MANUFACTURERS | 6 | 2025–2026 |
| SHOPIFY | 6 | 2024–2025 |
| ALLIANCE FOR HEALTH INFORMATION OPERATIONS AND STANDARDS | 5 | 2025–2026 |
| DELOITTE LLP | 5 | 2025–2026 |
| PATIENT SQUARE CAPITAL | 5 | 2025–2026 |
| MAKO MEDICAL | 4 | 2021 |
| PREVENT OPIOID ABUSE | 4 | 2022–2023 |
| QUIDNET ENERGY INC. | 4 | 2022 |
| SIERRA CLUB | 4 | 2024 |
| UNITED THERAPEUTICS CORPORATION | 4 | 2025–2026 |
| VULCANFORMS, INC. | 4 | 2023 |
| DH DIAGNOSTICS, LLC | 3 | 2026 |
| EMD MILLIPORE | 3 | 2021–2022 |
| LABWARE, INC. | 3 | 2021 |
| NATIONAL STRATEGIES, LLC (OBO VULCANFORMS, INC.) | 3 | 2023 |
| ZYMERGEN INC. | 2 | 2021 |
| CORTEXYME, INC. | 1 | 2021 |
| MONKTON, INC. | 1 | 2023 |
Supporting the Local Radio Freedom Act.
Client: NATIONAL ASSN OF BROADCASTERS · Firm: TIBER CREEK GROUP
Issues related to H. Con. Res. 12/S. Con. Res. 8 - Supporting the Local Radio Freedom Act.
Maintaining Investments in New Innovation Act
Client: ALNYLAM PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Medicare and Medicaid drug pricing.
Maintaining Investments in New Innovation Act
Client: ALNYLAM PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Medicare and Medicaid drug pricing.
Maintaining Investments in New Innovation Act
Client: ALNYLAM PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Medicare and Medicaid drug pricing.
Saving Our Veterans Lives Act of 2025
Client: EVERYTOWN FOR GUN SAFETY ACTION FUND · Firm: TIBER CREEK GROUP
Issues related to H.R. 1987/S. 926 - Saving Our Veterans Lives Act of 2025.
Saving Our Veterans Lives Act of 2025
Client: EVERYTOWN FOR GUN SAFETY ACTION FUND · Firm: TIBER CREEK GROUP
Issues related to H.R. 1987/S. 926 - Saving Our Veterans Lives Act of 2025.
Generating Retirement Ownership through Long-Term Holding
Client: PRIMERICA, INC. · Firm: TIBER CREEK GROUP
General issues related to life insurance; Issues related to data privacy; Issues related to electronic delivery (e-delivery); Issues related to H.R. 3383 - Incentivizing New Ventures and Economic Strength Through Capital Formation (INVEST) Act of 2025; Issues related to H.R. 2089/S. 1839 - Generating Retirement Ownership through Longer-Term Holding (GROWTH) Act; Issues related to H.R. 8338 - SAFER Act of 2026.
Generating Retirement Ownership through Long-Term Holding
Client: PRIMERICA, INC. · Firm: TIBER CREEK GROUP
General issues related to life insurance; Issues related to data privacy; Issues related to electronic delivery (e-delivery); Issues related to H.R. 3383 - Incentivizing New Ventures and Economic Strength Through Capital Formation (INVEST) Act of 2025; Issues related to H.R. 2089/S. 1839 - Generating Retirement Ownership through Longer-Term Holding (GROWTH) Act; Issues related to H.R. 8338 - SAFER Act of 2026.
Ensuring Community Access to Pharmacist Services Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Access to Prescription Digital Therapeutics Act of 2025
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Access to Prescription Digital Therapeutics Act of 2025
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Access to Prescription Digital Therapeutics Act of 2025
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025. Issues related to H.R. 7871/S. 1637 - MVP Act.
Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025
Client: PRIMERICA, INC. · Firm: TIBER CREEK GROUP
General issues related to life insurance; Issues related to data privacy; Issues related to electronic delivery (e-delivery); Issues related to H.R. 3383 - Incentivizing New Ventures and Economic Strength Through Capital Formation (INVEST) Act of 2025.
Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025
Client: PRIMERICA, INC. · Firm: TIBER CREEK GROUP
General issues related to life insurance; Issues related to data privacy; Issues related to electronic delivery (e-delivery); Issues related to H.R. 3383 - Incentivizing New Ventures and Economic Strength Through Capital Formation (INVEST) Act of 2025; Issues related to H.R. 2089/S. 1839 - Generating Retirement Ownership through Longer-Term Holding (GROWTH) Act; Issues related to H.R. 8338 - SAFER Act of 2026.
Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025
Client: PRIMERICA, INC. · Firm: TIBER CREEK GROUP
General issues related to life insurance; Issues related to data privacy; Issues related to electronic delivery (e-delivery); Issues related to H.R. 3383 - Incentivizing New Ventures and Economic Strength Through Capital Formation (INVEST) Act of 2025; Issues related to H.R. 2089/S. 1839 - Generating Retirement Ownership through Longer-Term Holding (GROWTH) Act; Issues related to H.R. 8338 - SAFER Act of 2026.
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Patients Deserve Price Tags Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
Patients Deserve Price Tags Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
Patients Deserve Price Tags Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to point of care testing and digital pathology; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to point of care testing and digital pathology; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to infectious disease diagnostics.
Issues related to point of care testing; Issues related to H.R. 7352 - PASTEUR Act of 2026.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025. Issues related to H.R. 7871/S. 1637 - MVP Act.
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
To amend title XVIII of the Social Security Act to establish a full risk ACO program.
Client: AGILON HEALTH, INC. · Firm: TIBER CREEK GROUP
Issues related to value-based health care, including Medicare Advantage (MA) and ACO models; Issues related to Medicare Shared Savings Program (MSSP); Issues related to the LEAD Model; Issues related to H.R. 9693 - Patients First Act of 2026, including APM bonus payments; Issues related to H.R. 8129 - To amend title XVIII of the Social Security Act to establish a full risk ACO program; Issues related to CMS innovation and payment model activities through CMMI.
To amend title XVIII of the Social Security Act to establish a full risk ACO program.
Client: AGILON HEALTH, INC. · Firm: TIBER CREEK GROUP
Issues related to value-based health care, including Medicare Advantage (MA) and ACO models; Issues related to Medicare Shared Savings Program (MSSP); Issues related to the ACO REACH Model; Issues related to the LEAD Model; Issues related to MA data sharing; Issues related to physician reimbursement and MACRA-related policies, including APM bonus payments; Issues related to H.R. 8129 - To amend title XVIII of the Social Security Act to establish a full risk ACO program; Issues related to CMS innovation and payment model activities through CMMI.
To amend title XVIII of the Social Security Act to establish a full risk ACO program.
Client: ACCOUNTABLE FOR HEALTH · Firm: TIBER CREEK GROUP
Issues related to value-based health care, including the Medicare Shared Savings Program (MSSP), ACO Reach Program and Comprehensive Kidney Care Contracting demonstration program; Issues related to physician reimbursement, including reforms to the Medicare Access and CHIP Reauthorization Act of 2015 (PL 114-10); Issues related to H.R. 8129 - To amend title XVIII of the Social Security Act to establish a full risk ACO program.
To amend title XVIII of the Social Security Act to establish a full risk ACO program.
Client: ACCOUNTABLE FOR HEALTH · Firm: TIBER CREEK GROUP
Issues related to value-based health care, including the Medicare Shared Savings Program (MSSP), ACO Reach Program and Comprehensive Kidney Care Contracting demonstration program; Issues related to physician reimbursement, including reforms to the Medicare Access and CHIP Reauthorization Act of 2015 (PL 114-10); Issues related to H.R. 8129 - To amend title XVIII of the Social Security Act to establish a full risk ACO program.
General issues related to life insurance; Issues related to data privacy; Issues related to electronic delivery (e-delivery); Issues related to H.R. 3383 - Incentivizing New Ventures and Economic Strength Through Capital Formation (INVEST) Act of 2025; Issues related to H.R. 2089/S. 1839 - Generating Retirement Ownership through Longer-Term Holding (GROWTH) Act; Issues related to H.R. 8338 - SAFER Act of 2026.
General issues related to life insurance; Issues related to data privacy; Issues related to electronic delivery (e-delivery); Issues related to H.R. 3383 - Incentivizing New Ventures and Economic Strength Through Capital Formation (INVEST) Act of 2025; Issues related to H.R. 2089/S. 1839 - Generating Retirement Ownership through Longer-Term Holding (GROWTH) Act; Issues related to H.R. 8338 - SAFER Act of 2026.
Making appropriations for national security, Department of State, and related programs for the fiscal year ending September 30, 2027, and for other purposes.
Client: ABBOTT LABORATORIES · Firm: TIBER CREEK GROUP
Issues related to global health policy and funding; Issues related to H.R. 8595 - National Security, Department of State, and Related Programs Appropriations Act, 2027; Issues pertaining to third party litigation funding; Issues pertaining to H.R. 8845 - Commerce, Justice, Science, and Related Appropriations Act.
Making appropriations for national security, Department of State, and related programs for the fiscal year ending September 30, 2027, and for other purposes.
Client: ABBOTT LABORATORIES · Firm: TIBER CREEK GROUP
Issues related to global health policy and funding; Issues related to H.R. 8595 - National Security, Department of State, and Related Programs Appropriations Act, 2027.
National Defense Authorization Act for Fiscal Year 2027
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Pharmacy issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
National Defense Authorization Act for Fiscal Year 2027
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Pharmacy issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027
Client: ABBOTT LABORATORIES · Firm: TIBER CREEK GROUP
Issues related to global health policy and funding; Issues related to H.R. 8595 - National Security, Department of State, and Related Programs Appropriations Act, 2027; Issues pertaining to third party litigation funding; Issues pertaining to H.R. 8845 - Commerce, Justice, Science, and Related Appropriations Act.
Energy and Water Development and Related Agencies Appropriations Act, 2027
Client: NUSANO, INC. · Firm: TIBER CREEK GROUP
Issues related to funding for domestic radioisotopes, uranium, and nuclear fuel rod remediation and recycling; Issues related to H.R. 9022 - Energy and Water Development and Related Agencies Appropriations Act, 2027.
Energy and Water Development and Related Agencies Appropriations Act, 2027
Client: NUSANO, INC. · Firm: TIBER CREEK GROUP
Issues related to funding for domestic radioisotopes, uranium, and nuclear fuel rod remediation and recycling; Issues related to H.R. 9022 - Energy and Water Development and Related Agencies Appropriations Act, 2027.
Protect College Sports Act of 2026
Client: NATIONAL ASSN OF BROADCASTERS · Firm: TIBER CREEK GROUP
Issues related to local broadcasting; Issues related to H.R. 979/S. 315 - AM Radio for Every Vehicle Act of 2025; Issues related to media ownership rules; Issues related to ATSC 3.0; Issues related to H.R. 9137/S. 4668 - Protect College Sports Act of 2026; Issues related to local broadcasters.
Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Medicare and Medicaid drug pricing.
Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Medicare and Medicaid drug pricing.
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to the Medicaid Pricing reform; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to Medicaid Rebates; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.
Issues related to value-based health care, including Medicare Advantage (MA) and ACO models; Issues related to Medicare Shared Savings Program (MSSP); Issues related to the LEAD Model; Issues related to H.R. 9693 - Patients First Act of 2026, including APM bonus payments; Issues related to H.R. 8129 - To amend title XVIII of the Social Security Act to establish a full risk ACO program; Issues related to CMS innovation and payment model activities through CMMI.
AM Radio for Every Vehicle Act of 2025
Client: NATIONAL ASSN OF BROADCASTERS · Firm: TIBER CREEK GROUP
Issues related to local broadcasting; Issues related to H.R. 979/S. 315 - AM Radio for Every Vehicle Act of 2025; Issues related to media ownership rules; Issues related to ATSC 3.0; Issues related to H.R. 9137/S. 4668 - Protect College Sports Act of 2026; Issues related to local broadcasters.
AM Radio for Every Vehicle Act of 2025
Client: NATIONAL ASSN OF BROADCASTERS · Firm: TIBER CREEK GROUP
Issues related to local broadcasting; Issues related to H.R. 979/S. 315 - AM Radio for Every Vehicle Act of 2025; Issues related to media ownership rules; Issues related to ATSC 3.0.
AM Radio for Every Vehicle Act of 2025
Client: NATIONAL ASSN OF BROADCASTERS · Firm: TIBER CREEK GROUP
Issues related to local broadcasting; Issues related to H.R. 979/S. 315 - AM Radio for Every Vehicle Act of 2025; Issues related to media ownership rules; Issues related to ATSC 3.0.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025. Issues related to H.R. 7871/S. 1637 - MVP Act.
Access to Prescription Digital Therapeutics Act of 2025
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Access to Prescription Digital Therapeutics Act of 2025
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Access to Prescription Digital Therapeutics Act of 2025
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025. Issues related to H.R. 7871/S. 1637 - MVP Act.
Generating Retirement Ownership through Long-Term Holding
Client: PRIMERICA, INC. · Firm: TIBER CREEK GROUP
General issues related to life insurance; Issues related to data privacy; Issues related to electronic delivery (e-delivery); Issues related to H.R. 3383 - Incentivizing New Ventures and Economic Strength Through Capital Formation (INVEST) Act of 2025; Issues related to H.R. 2089/S. 1839 - Generating Retirement Ownership through Longer-Term Holding (GROWTH) Act; Issues related to H.R. 8338 - SAFER Act of 2026.
Generating Retirement Ownership through Long-Term Holding
Client: PRIMERICA, INC. · Firm: TIBER CREEK GROUP
General issues related to life insurance; Issues related to data privacy; Issues related to electronic delivery (e-delivery); Issues related to H.R. 3383 - Incentivizing New Ventures and Economic Strength Through Capital Formation (INVEST) Act of 2025; Issues related to H.R. 2089/S. 1839 - Generating Retirement Ownership through Longer-Term Holding (GROWTH) Act; Issues related to H.R. 8338 - SAFER Act of 2026.
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to Medicaid Rebates; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.
Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Medicare and Medicaid drug pricing.
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to the Medicaid Pricing reform; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.
Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Medicare and Medicaid drug pricing.
Patients Deserve Price Tags Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
Patients Deserve Price Tags Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
Patients Deserve Price Tags Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
Equitable Community Access to Pharmacist Services Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Health Information Privacy Reform Act
Client: ALLIANCE FOR HEALTH INFORMATION OPERATIONS AND STANDARDS · Firm: TIBER CREEK GROUP
Issues related to protected health information; Issues related to S. 3097 - Health Information Privacy Reform Act; Issues related to the Health Insurance Portability and Accountability Act (HIPAA) (PL 104-191) Privacy Rule: Changes to Support Coordinated Care and Individual Engagement and Reduce Regulatory Burdens.
Health Information Privacy Reform Act
Client: ALLIANCE FOR HEALTH INFORMATION OPERATIONS AND STANDARDS · Firm: TIBER CREEK GROUP
Issues related to protected health information; Issues related to S. 3097 - Health Information Privacy Reform Act; Issues related to the Health Insurance Portability and Accountability Act (HIPAA) (PL 104-191) Privacy Rule: Changes to Support Coordinated Care and Individual Engagement and Reduce Regulatory Burdens.
Health Information Privacy Reform Act
Client: ALLIANCE FOR HEALTH INFORMATION OPERATIONS AND STANDARDS · Firm: TIBER CREEK GROUP
Issues related to protected health information; Issues related to S. 3097 - Health Information Privacy Reform Act; Issues related to the Health Insurance Portability and Accountability Act (HIPAA) (PL 104-191) Privacy Rule: Changes to Support Coordinated Care and Individual Engagement and Reduce Regulatory Burdens.
AM Radio for Every Vehicle Act of 2025
Client: NATIONAL ASSN OF BROADCASTERS · Firm: TIBER CREEK GROUP
Issues related to local broadcasting; Issues related to H.R. 979/S. 315 - AM Radio for Every Vehicle Act of 2025; Issues related to media ownership rules; Issues related to ATSC 3.0; Issues related to H.R. 9137/S. 4668 - Protect College Sports Act of 2026; Issues related to local broadcasters.
Issues related to telemedicine and the rural health transformation fund.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NUSANO, INC. via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to promoting domestic production of radioisotopes, High-Assay Low-Enriched Uranium (HALEU) and critical minerals.
Issues related to funding for domestic radioisotopes, uranium, and nuclear fuel rod remediation and recycling; Issues related to H.R. 9022 - Energy and Water Development and Related Agencies Appropriations Act, 2027.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
EVERYTOWN FOR GUN SAFETY ACTION FUND via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to gun safety.
Issues related to H.R. 1987/S. 926 - Saving Our Veterans Lives Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CORROHEALTH, INC. via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to Medicare Advantage and Medicare Program Integrity.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATION AND SUBSIDIARIES via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
Issues related to Medicare drug coverage, specialty pharmacy, and general prescription drug pricing policy.
Issues related to pharmacy and prescription drug pricing; Issues relating to implementation of the No Surprises Act (PL 116-260); Issues related to price transparency.
Pharmacy issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR HEALTH INFORMATION OPERATIONS AND STANDARDS via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to protected health information; Issues related to S. 3097 - Health Information Privacy Reform Act; Issues related to the Health Insurance Portability and Accountability Act (HIPAA) (PL 104-191) Privacy Rule: Changes to Support Coordinated Care and Individual Engagement and Reduce Regulatory Burdens.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
AGILON HEALTH, INC. via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to value-based health care, including Medicare Advantage (MA) and ACO models; Issues related to Medicare Shared Savings Program (MSSP); Issues related to the LEAD Model; Issues related to H.R. 9693 - Patients First Act of 2026, including APM bonus payments; Issues related to H.R. 8129 - To amend title XVIII of the Social Security Act to establish a full risk ACO program; Issues related to CMS innovation and payment model activities through CMMI.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACCOUNTABLE FOR HEALTH via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to value-based health care, including the Medicare Shared Savings Program (MSSP), ACO Reach Program and Comprehensive Kidney Care Contracting demonstration program; Issues related to physician reimbursement, including reforms to the Medicare Access and CHIP Reauthorization Act of 2015 (PL 114-10); Issues related to H.R. 8129 - To amend title XVIII of the Social Security Act to establish a full risk ACO program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADIA PHARMACEUTICALS, INC. via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to drug pricing; Issues related to the Inflation Reduction Act (PL 117-169).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELOITTE LLP via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to government funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSN OF BROADCASTERS via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to local broadcasting; Issues related to H.R. 979/S. 315 - AM Radio for Every Vehicle Act of 2025; Issues related to media ownership rules; Issues related to ATSC 3.0; Issues related to H.R. 9137/S. 4668 - Protect College Sports Act of 2026; Issues related to local broadcasters.
Issues related to H. Con. Res. 12/S. Con. Res. 8 - Supporting the Local Radio Freedom Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOLVENTUM CORPORATION via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.
Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INCYTE CORPORATION via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to Medicaid Rebates; Issues related to Health and Human Services Center for Medicare and Medicaid Innovation GUARD Demo; Issues related to Medicare coverage of Vitilligo.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOM ENERGY via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to implementation of USC 48(c)(1)(E) - Qualified fuel cell property.
Issues related to the deployment of fuel cells, electrolyzers, hydrogen, and carbon capture; Issues related to onsite power generation and grid stability; Issues related to permitting reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to the Medicaid Pricing reform.
Issues related to the 340B Program - Public Health Service Act (PL 78-410).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALNYLAM PHARMACEUTICALS, INC. via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Medicare and Medicaid drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DH DIAGNOSTICS LLC via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to funding for diagnostics.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to point of care testing and digital pathology; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to infectious disease diagnostics.
NATIONAL ASSOCIATION OF MANUFACTURERS via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to manufacturing, including proposed rules required in the Modernization of Cosmetics Regulation Act of 2022 (PL 117 - 328).
Issues related to food safety and food supply chains.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACADEMY OF MANAGED CARE PHARMACY via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIMERICA, INC. via TIBER CREEK GROUP
2026 · third_quarter · Q3
General issues related to life insurance; Issues related to data privacy; Issues related to electronic delivery (e-delivery); Issues related to H.R. 3383 - Incentivizing New Ventures and Economic Strength Through Capital Formation (INVEST) Act of 2025; Issues related to H.R. 2089/S. 1839 - Generating Retirement Ownership through Longer-Term Holding (GROWTH) Act; Issues related to H.R. 8338 - SAFER Act of 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GEORGIALINK PUBLIC AFFAIRS GROUP, LLC (O.B.O. DOUGHERTY COUNTY, GA) via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to general appropriations; Issues related to federal grant opportunities; General state and local issues.
Issues related to general appropriations; Issues related to federal grant opportunities; General state and local issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to global health policy and funding; Issues related to H.R. 8595 - National Security, Department of State, and Related Programs Appropriations Act, 2027; Issues pertaining to third party litigation funding; Issues pertaining to H.R. 8845 - Commerce, Justice, Science, and Related Appropriations Act.
Issues related to global health policy and funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COX MEDIA GROUP via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues facing local broadcasters.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COX MEDIA GROUP via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues facing local broadcasters.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADIA PHARMACEUTICALS, INC. via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to drug pricing; Issues related to the Inflation Reduction Act (PL 117-169).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELOITTE LLP via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to government funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DH DIAGNOSTICS LLC via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to point of care testing and digital pathology; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026.
Issues related to funding for diagnostics.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSN OF BROADCASTERS via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to local broadcasting; Issues related to H.R. 979/S. 315 - AM Radio for Every Vehicle Act of 2025; Issues related to media ownership rules; Issues related to ATSC 3.0.
Issues related to H. Con. Res. 12/S. Con. Res. 8 - Supporting the Local Radio Freedom Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF MANUFACTURERS via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to food safety and food supply chains.
Issues related to manufacturing, including proposed rules required in the Modernization of Cosmetics Regulation Act of 2022 (PL 117-328).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITED THERAPEUTICS CORPORATION via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to organs and xenotransplantation.
Filing targets: HOUSE OF REPRESENTATIVES
ACADEMY OF MANAGED CARE PHARMACY via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENT SQUARE CAPITAL via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to telemedicine and the rural health transformation fund.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NUSANO, INC. via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to promoting domestic production of radioisotopes, High-Assay Low-Enriched Uranium (HALEU) and critical minerals.
Issues related to funding for domestic radioisotopes, uranium, and nuclear fuel rod remediation and recycling; Issues related to H.R. 9022 - Energy and Water Development and Related Agencies Appropriations Act, 2027.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EVERYTOWN FOR GUN SAFETY ACTION FUND via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to gun safety.
Issues related to H.R. 1987/S. 926 - Saving Our Veterans Lives Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CORROHEALTH, INC. via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to Medicare Advantage and Medicare Program Integrity.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATION AND SUBSIDIARIES via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to pharmacy and prescription drug pricing; Issues relating to implementation of the No Surprises Act (PL 116-260); Issues related to price transparency.
Pharmacy issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
AGILON HEALTH, INC. via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to value-based health care, including Medicare Advantage (MA) and ACO models; Issues related to Medicare Shared Savings Program (MSSP); Issues related to the ACO REACH Model; Issues related to the LEAD Model; Issues related to MA data sharing; Issues related to physician reimbursement and MACRA-related policies, including APM bonus payments; Issues related to H.R. 8129 - To amend title XVIII of the Social Security Act to establish a full risk ACO program; Issues related to CMS innovation and payment model activities through CMMI.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACCOUNTABLE FOR HEALTH via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to value-based health care, including the Medicare Shared Savings Program (MSSP), ACO Reach Program and Comprehensive Kidney Care Contracting demonstration program; Issues related to physician reimbursement, including reforms to the Medicare Access and CHIP Reauthorization Act of 2015 (PL 114-10); Issues related to H.R. 8129 - To amend title XVIII of the Social Security Act to establish a full risk ACO program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR HEALTH INFORMATION OPERATIONS AND STANDARDS via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to protected health information; Issues related to S. 3097 - Health Information Privacy Reform Act; Issues related to the Health Insurance Portability and Accountability Act (HIPAA) (PL 104-191) Privacy Rule: Changes to Support Coordinated Care and Individual Engagement and Reduce Regulatory Burdens.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
INCYTE CORPORATION via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to Medicaid Rebates; Issues related to Health and Human Services Center for Medicare and Medicaid Innovation GUARD Demo.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOM ENERGY via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to the deployment of fuel cells, electrolyzers, hydrogen, and carbon capture; Issues related to onsite power generation and grid stability.
Issues related to implementation of USC 48(c)(1)(E) - Qualified fuel cell property.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to the Department of Defense, Uniform Formulary Beneficiary Advisory Panel.
Issues related to the 340B Program - Public Health Service Act (PL 78-410).
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to the Medicaid Pricing reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GEORGIALINK PUBLIC AFFAIRS GROUP, LLC (O.B.O. DOUGHERTY COUNTY, GA) via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to general appropriations; Issues related to federal grant opportunities; General state and local issues.
Issues related to general appropriations; Issues related to federal grant opportunities; General state and local issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALNYLAM PHARMACEUTICALS, INC. via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Medicare and Medicaid drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to global health policy and funding; Issues related to H.R. 8595 - National Security, Department of State, and Related Programs Appropriations Act, 2027.
Issues related to global health policy and funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIMERICA, INC. via TIBER CREEK GROUP
2026 · second_quarter · Q2
General issues related to life insurance; Issues related to data privacy; Issues related to electronic delivery (e-delivery); Issues related to H.R. 3383 - Incentivizing New Ventures and Economic Strength Through Capital Formation (INVEST) Act of 2025; Issues related to H.R. 2089/S. 1839 - Generating Retirement Ownership through Longer-Term Holding (GROWTH) Act; Issues related to H.R. 8338 - SAFER Act of 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOLVENTUM CORPORATION via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.
Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOLVENTUM CORPORATION via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.
Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DH DIAGNOSTICS LLC via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to point of care testing; Issues related to H.R. 7352 - PASTEUR Act of 2026.
Issues related to funding for diagnostics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIMERICA, INC. via TIBER CREEK GROUP
2026 · first_quarter · Q1
General issues related to life insurance; Issues related to data privacy; Issues related to electronic delivery (e-delivery); Issues related to H.R. 3383 - Incentivizing New Ventures and Economic Strength Through Capital Formation (INVEST) Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COX MEDIA GROUP via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues facing local broadcasters.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATION AND SUBSIDIARIES via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to pharmacy and prescription drug pricing; Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to the extension of Enhanced Advanced Premium Tax Credits (EAPTCs) in the American Rescue Plan Act (PL 117-2) and the Inflation Reduction Act (PL 117-169); Issues relating to implementation of the No Surprises Act (PL 116-260).
Pharmacy issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
PATIENT SQUARE CAPITAL via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to telemedicine and the rural health transformation fund.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NUSANO, INC. via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to promoting domestic production of radioisotopes, High-Assay Low-Enriched Uranium (HALEU) and critical minerals.
Issues related to funding for domestic radioisotopes, uranium, and nuclear fuel rod remediation and recycling.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
EVERYTOWN FOR GUN SAFETY ACTION FUND via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to gun safety.
Issues related to S. 926 - Saving Our Veterans Lives Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CORROHEALTH, INC. via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to Medicare Advantage and Medicare Program Integrity.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR HEALTH INFORMATION OPERATIONS AND STANDARDS via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to protected health information; Issues related to S. 3097 - Health Information Privacy Reform Act; Issues related to the Health Insurance Portability and Accountability Act (HIPAA) (PL 104-191) Privacy Rule: Changes to Support Coordinated Care and Individual Engagement and Reduce Regulatory Burdens.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
AGILON HEALTH, INC. via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to value-based health care, including the Medicare Shared Savings Program (MSSP) and the ACO Reach Program; Issues related to Medicare Advantage; Issues related to the extension of Alternative Payment Model bonus payments and physician reimbursement, including the Medicare Access and CHIP Reauthorization Act of 2015 (PL 114-10) and the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to Medicare payment demonstration projects.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ACCOUNTABLE FOR HEALTH via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to value-based health care; Issues related to reforming provider payments and the adoption of accountable care; Issues related to Medicare payment demonstration projects; Issues related to reforming payments for skin substitute treatments in the Calendar Year 2026 Medicare Physician Fee Schedule Rule; Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ACADIA PHARMACEUTICALS, INC. via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to rare disease treatments, including rare disease research incentives; Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to drug pricing reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSN OF BROADCASTERS via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to H. Con. Res. 12/S. Con. Res. 8 - Supporting the Local Radio Freedom Act.
Issues related to local broadcasting; Issues related to H.R. 979/S. 315 - AM Radio for Every Vehicle Act of 2025; Issues related to media ownership rules; Issues related to ATSC 3.0.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELOITTE LLP via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to government funding.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF MANUFACTURERS via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to manufacturing, including proposed rules required in the Modernization of Cosmetics Regulation Act of 2022 (PL 117 - 328).
Issues related to food safety and food supply chains.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACADEMY OF MANAGED CARE PHARMACY via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025. Issues related to H.R. 7871/S. 1637 - MVP Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GEORGIALINK PUBLIC AFFAIRS GROUP, LLC (O.B.O. DOUGHERTY COUNTY, GA) via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to general appropriations; Issues related to federal grant opportunities; General state and local issues.
Issues related to general appropriations; Issues related to federal grant opportunities; General state and local issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to global health policy and funding; Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75).
Issues related to global health policy and funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INCYTE CORPORATION via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to Medicaid Rebates; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOM ENERGY via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to implementation of USC 48(c)(1)(E) - Qualified fuel cell property.
Issues related to the deployment of fuel cells, electrolyzers, hydrogen, and carbon capture; Issues related to onsite power generation and grid stability.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to the 340B Program - Public Health Service Act (PL 78-410).
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to the Medicaid Pricing reform; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALNYLAM PHARMACEUTICALS, INC. via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Medicare and Medicaid drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INCYTE CORPORATION via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to Medicaid Rebates; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOM ENERGY via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to implementation of USC 48(c)(1)(E) - Qualified fuel cell property.
Issues related to the deployment of fuel cells, electrolyzers, hydrogen, and carbon capture; Issues related to onsite power generation and grid stability.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to the 340B Program - Public Health Service Act (P.L. 78-410).
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to the Medicaid Pricing reform; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALNYLAM PHARMACEUTICALS, INC. via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Medicare and Medicaid drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIMERICA, INC. via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
General issues related to life insurance; Issues related to data privacy; Issues related to electronic delivery (e-delivery); Issues related to H.R. 3383 - Incentivizing New Ventures and Economic Strength Through Capital Formation (INVEST) Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED THERAPEUTICS CORPORATION via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to USPS zip code changes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENT SQUARE CAPITAL via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to telemedicine and the rural health transformation fund.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NUSANO, INC. via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to promoting domestic production of radioisotopes, High-Assay Low-Enriched Uranium (HALEU) and critical minerals.
Issues related to funding for domestic radioisotopes, uranium, and nuclear fuel rod remediation and recycling.
Filing targets: Defense, Dept of (DOD), Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE, White House Office
EVERYTOWN FOR GUN SAFETY ACTION FUND via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to gun safety.
Issues related to gun safety and funding for ATF.
Issues related to gun safety and tax incentives for secure storage.
CORROHEALTH, INC. via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to Medicare Advantage and Medicare Program Integrity.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATION AND SUBSIDIARIES via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to Medicare drug coverage, specialty pharmacy, and general prescription drug pricing policy; Issues related to the continuation of telehealth flexibilities.
Issues related to proposals impacting employer-sponsored insurance; Issues related to pharmacy and prescription drug pricing policy; Issues related to H.R. 247/S. 846 - Health Care Affordability Act of 2025; Issues related to the extension of Enhanced Advanced Premium Tax Credits (EAPTCs) in the American Rescue Plan Act (PL 117-2) and the Inflation Reduction Act (PL 117-169).
Pharmacy issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
ALLIANCE FOR HEALTH INFORMATION OPERATIONS AND STANDARDS via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to protected health information; Issues related to S. 3097 - Health Information Privacy Reform Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AGILON HEALTH, INC. via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to value-based health care, including the Medicare Shared Savings Program (MSSP) and the ACO Reach Program; Issues related to Medicare Advantage, including S. 1105 - No UPCODE Act; Issues related to the extension of Alternative Payment Model bonus payments and physician reimbursement, including the Medicare Access and CHIP Reauthorization Act of 2015 (PL 114-10); Issues related to the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (PL 119-37), including issues related to the continuation of Medicare telehealth flexibilities; Issues related to Medicare payment demonstration projects.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ACCOUNTABLE FOR HEALTH via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to value-based health care; Issues related to reforming provider payments and the adoption of accountable care; Issues related to Medicare payment demonstration projects; Issues related to reforming payments for skin substitute treatments in the Calendar Year 2026 Medicare Physician Fee Schedule Rule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ACADIA PHARMACEUTICALS, INC. via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to rare disease treatments, including rare disease research incentives; Issues related to H.R. 1262/S. 932 - Give Kids a Chance Act; Issues related to Medicaid changes in the One Big Beautiful Bill Act (PL 119-21); Issues related to drug pricing reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COX MEDIA GROUP via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues facing local broadcasters.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF MANUFACTURERS via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to manufacturing, including proposed rules required in the Modernization of Cosmetics Regulation Act of 2022 (PL 117 - 328).
Issues related to food safety and food supply chains.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACADEMY OF MANAGED CARE PHARMACY via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSN OF BROADCASTERS via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to local broadcasting; Issues related to H.R. 979/S. 315 - AM Radio for Every Vehicle Act of 2025; Issues related to media ownership rules; Issues related to ATSC 3.0.
Issues related to H. Con. Res. 12/S. Con. Res. 8 - Supporting the Local Radio Freedom Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELOITTE LLP via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to government funding.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GEORGIALINK PUBLIC AFFAIRS GROUP, LLC (O.B.O. DOUGHERTY COUNTY, GA) via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to general appropriations; Issues related to federal grant opportunities; General state and local issues.
Issues related to general appropriations; Issues related to federal grant opportunities; General state and local issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to global health policy and funding.
Issues related to global health policy and funding; H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOLVENTUM CORPORATION via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.
Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (PL 119-37).
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (PL 119-37).
ALLIANCE FOR HEALTH INFORMATION OPERATIONS AND STANDARDS via TIBER CREEK GROUP
2025 · fourth_quarter · RR
Issues related to the exchange of healthcare data.
PRIMERICA, INC. via TIBER CREEK GROUP
2025 · third_quarter · Q3
General issues related to life insurance; Issues related to data privacy; Issues related to electronic delivery (e-delivery).
Issues related to 2025 tax reform; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to Medicare drug coverage, specialty pharmacy, and general prescription drug pricing policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to S. 926 - Saving Our Veterans Lives Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Filing targets: HOUSE OF REPRESENTATIVES, SENATE